New Drug Approvals

• Scemblix (asciminib) TabletsDate of Approval: October 29, 2021
  Treatment for: Chronic Myelogenous Leukemia
  Press Release | Approval History
• Vuity (pilocarpine hydrochloride) Ophthalmic SolutionDate of Approval: October 28, 2021
  Treatment for: Presbyopia
  Press Release | Approval History
• Susvimo (ranibizumab) Injection for Intravitreal Use via Ocular ImplantDate of Approval: October 25, 2021
  Treatment for:
  Press Release | Approval History
• Xipere (triamcinolone acetonide) InjectionDate of Approval: October 22, 2021
  Treatment for: Macular Edema, Uveitis
  Press Release | Approval History
• Zimhi (naloxone hydrochloride) InjectionDate of Approval: October 15, 2021
  Treatment for: Opioid Overdose
  Press Release | Approval History
• Seglentis (celecoxib and tramadol hydrochloride) TabletsDate of Approval: October 15, 2021
  Treatment for: Pain
  Press Release | Approval History
• Tyrvaya (varenicline) Nasal SprayDate of Approval: October 15, 2021
  Treatment for: Dry Eye Disease
  Press Release | Approval History
• Rethymic (allogeneic processed thymus tissue-agdc) for Surgical ImplantationDate of Approval: October 8, 2021
  Treatment for: Congenital Athymia
  Press Release | Approval History
• Tavneos (avacopan) CapsulesDate of Approval: October 7, 2021
  Treatment for: ANCA-Associated Vasculitis
  Press Release | Approval History